by Harvard T.H. Chan School of Public Health Credit: Pixabay/CC0 Public Domain People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)—a highly effective treatment for the disease—both across and within U.S. states, according to new research co-authored by researchers from Harvard T.H....
AMERICAN ASSOCIATION FOR CANCER RESEARCH Bottom Line: Individuals between 20 and 39 years old experienced the steepest increase in distant-stage early-onset colorectal adenocarcinoma incidence between 2000 and 2016, with the youngest non-Hispanic Black and Hispanic populations experiencing greater proportions of distant-stage disease. Journal in Which the Study was Published: Cancer Epidemiology, Biomarkers & Prevention, a journal of...
